Opioid Addiction and Its Impact on Actuarial Science

Dr. James Kim
Gayle Kanchanapume

In Brief

Curious about RGA's medical insights? Contact us to learn more.

This video was developed in conjunction with actuview, the first permanent international media platform for actuaries (www.actuview.com). actuview content reflects contributions from actuarial institutions, corporate partners and industry professionals. RGA is actuview’s sponsoring partner.

Amid the global focus on the COVID-19 pandemic, the opioid epidemic has continued to worsen.

Join Dr. James Kim, Medical Director at the Centers for Pain Management in Brampton, Ontario, and Gayle Kanchanapume, Executive Director, RGA Global Claims, as they discuss the global opioid epidemic and its effects both on society and on insurance.

Learn about the alarming rise in opioid use and addiction worldwide. Explore the far-reaching impacts of the global opioid epidemic, and hear insights from experts, including advice for risk managers.

See also: Opioid Prescription: History Analysis

At RGA, we are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to discuss and learn more about the RGA capabilities, resources, and solutions.

Meet the Authors & Experts

Expert

Dr. James Kim

Consultant CMO, RGA International Medical Director, NeuPath Centre for Pain and Spine

Expert

Gayle Kanchanapume

Executive Director, Global Claims Value Added Specialist. RGA Australia

Opioid Addiction and Its Impact on Actuarial Science

More Like This...

Related Solutions

Meet the Authors & Experts